BlackRock’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Sell |
1,828,614
-3,455,799
| -65% | -$4.94M | ﹤0.01% | 3924 |
|
|
2025
Q1 | $8.46M | Sell |
5,284,413
-274,438
| -5% | -$439K | ﹤0.01% | 3361 |
|
|
2024
Q4 | $20M | Buy |
5,558,851
+667,916
| +14% | +$2.4M | ﹤0.01% | 3015 |
|
|
2024
Q3 | $27.9M | Buy |
4,890,935
+339,425
| +7% | +$1.93M | ﹤0.01% | 2780 |
|
|
2024
Q2 | $21M | Buy |
4,551,510
+3,646,504
| +403% | +$16.8M | ﹤0.01% | 2919 |
|
|
2024
Q1 | $7.39M | Sell |
905,006
-898,427
| -50% | -$7.34M | ﹤0.01% | 3456 |
|
|
2023
Q4 | $10.2M | Sell |
1,803,433
-291,905
| -14% | -$1.65M | ﹤0.01% | 3319 |
|
|
2023
Q3 | $3.9M | Buy |
2,095,338
+8,775
| +0.4% | +$16.3K | ﹤0.01% | 3699 |
|
|
2023
Q2 | $5.74M | Sell |
2,086,563
-1,610,179
| -44% | -$4.43M | ﹤0.01% | 3593 |
|
|
2023
Q1 | $11.6M | Buy |
3,696,742
+75,609
| +2% | +$237K | ﹤0.01% | 3172 |
|
|
2022
Q4 | $21.4M | Buy |
3,621,133
+156,561
| +5% | +$924K | ﹤0.01% | 2944 |
|
|
2022
Q3 | $30.4M | Buy |
3,464,572
+66,974
| +2% | +$587K | ﹤0.01% | 2760 |
|
|
2022
Q2 | $25.6M | Buy |
3,397,598
+257,608
| +8% | +$1.94M | ﹤0.01% | 2893 |
|
|
2022
Q1 | $76.2M | Sell |
3,139,990
-265,992
| -8% | -$6.45M | ﹤0.01% | 2287 |
|
|
2021
Q4 | $110M | Buy |
3,405,982
+248,775
| +8% | +$8.01M | ﹤0.01% | 2147 |
|
|
2021
Q3 | $141M | Buy |
3,157,207
+524,783
| +20% | +$23.4M | ﹤0.01% | 1960 |
|
|
2021
Q2 | $99.6M | Buy |
2,632,424
+1,437,932
| +120% | +$54.4M | ﹤0.01% | 2236 |
|
|
2021
Q1 | $44.2M | Buy |
1,194,492
+54,901
| +5% | +$2.03M | ﹤0.01% | 2656 |
|
|
2020
Q4 | $37.8M | Buy |
+1,139,591
| New | +$37.8M | ﹤0.01% | 2596 |
|